Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 44,647
  • Shares Outstanding, K 19,162
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.97
Trade HUGE.CN with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.310 +0.87%
on 10/22/20
3.860 -39.64%
on 09/28/20
-1.220 (-34.37%)
since 09/23/20
3-Month
2.310 +0.87%
on 10/22/20
9.090 -74.37%
on 07/30/20
-2.780 (-54.40%)
since 07/23/20
52-Week
2.310 +0.87%
on 10/22/20
15.100 -84.57%
on 01/08/20
-2.920 (-55.62%)
since 10/23/19

Most Recent Stories

More News
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients

- FDA has authorized randomized, controlled, double-blind, multicenter study on 352 patients

HUGE.CN : 2.330 (-0.85%)
HUGE : 1.8100 (unch)
FSD Pharma Announces Phase 2 Clinical Trial IND Filing with the FDA to Treat Patients with COVID-19

- The study is expected to be conducted at 25-30 hospitals in North America -

HUGE.CN : 2.330 (-0.85%)
HUGE : 1.8100 (unch)
FSD Pharma Inc., Developing its PEA Compound to Treat COVID-19, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - CEO and Chairman, Raza Bokhari speaks about the company's lead Compound, PEA, to treat COVID-19.

HUGE.CN : 2.330 (-0.85%)
HUGE : 1.8100 (unch)
InvestmentPitch Media Video Discusses FSD Pharma's Report of Favorable Topline Results from Phase 1 First-in-Human Safety and Tolerability Study of Ultra-micronized PEA - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) -  FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9), a specialty, biotech pharmaceutical R&D company, focused on developing, over time,...

HUGE : 1.8100 (unch)
HUGE.CN : 2.330 (-0.85%)
FSD Pharma Reports Favorable Topline Results from Phase 1 First-in-Human Safety and Tolerability Study of Ultramicronized PEA

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced favorable topline results from its Phase 1 randomized, double-blind, placebo-controlled study of...

HUGE.CN : 2.330 (-0.85%)
HUGE : 1.8100 (unch)
FSD Pharma Announces Closing of C$10.125 Million Private Placement to Institutional Investors

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (the "Company") announces the closing of a previously announced private placement of 1,500,000 of the Company's Class B Subordinate Voting Shares...

HUGE.CN : 2.330 (-0.85%)
HUGE : 1.8100 (unch)
FSD Pharma Announces Closing of C$10.125 Million Private Placement to Institutional Investors

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (the "Company") announces the closing of a previously announced private placement of 1,500,000 of the Company's Class B Subordinate Voting Shares...

HUGE.CN : 2.330 (-0.85%)
HUGE : 1.8100 (unch)
FSD Pharma Inc. Announces C$10.125 Million Private Placement

FSD Pharma Inc. (NASDAQ: HUGE) ("FSD Pharma" or the "Company"), today announced it has entered into definitive agreements with certain institutional investors for the purchase and sale of 1,500,000 shares...

HUGE.CN : 2.330 (-0.85%)
HUGE : 1.8100 (unch)
IIROC Trade Resumption - HUGE

Trading resumes in:

HUGE.CN : 2.330 (-0.85%)
/C O R R E C T I O N -- Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions/

In the news release, IIROC Trade Resumption - HUGE, issued 03-Jun-2020 by Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions over CNW, we are advised by the company that...

HUGE.CN : 2.330 (-0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 2.423
1st Resistance Point 2.377
Last Price 2.330
1st Support Level 2.307
2nd Support Level 2.283

See More

52-Week High 15.100
Fibonacci 61.8% 10.214
Fibonacci 50% 8.705
Fibonacci 38.2% 7.196
Last Price 2.330
52-Week Low 2.310

See More

Business Summary

FSD Pharma Inc is a publicly traded company, through its wholly-owned subsidiary holds an Access to Cannabis for Medical Purposes Regulation license to cultivate cannabis. It is engaged in the production and sale of medical cannabis. All of the company's operations are situated in Canada.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar